Health

Cerebral announces transition plan in the context of controlled substance surveillance



Amid the controversy surrounding the digital mental health company’s prescribing practices and a week after replacing the CEO, Brain revealed a transformation plan focused on growth and patient experience.

The program, called Cerebral Core, includes goals to review quality practices as well as improve the experience for users and clinicians.

The company said it plans to add in-network insurance services, review marketing and clinical practices, expand its substance use disorder treatment programs, provide more tools more doctors to improve outcomes and invest in their technology platforms.

WHY IT IMPORTANT

The new plan comes a week after Cerebral announced that the former CEO and co-founder Kyle Robertson has left the company and will be replaced by Dr David Mou, who was the company’s chief medical officer.

Last week, the congested company also confirmed Insiders that it will stop prescribing most controlled substances. Cerebral is facing increasing scrutiny over its prescribing practices, particularly over drugs like Adderall for ADHD, including a federal investigation into may violate the Controlled Substances Act.

One former executive sued Cerebral, alleging that he was fired after raising concerns about prescribing and patient safety. In his suit, he said Cerebral’s goal is to prescribe the drug to all of its ADHD patients to increase retention, and that the company doesn’t prioritize investigating duplicate shipping addresses in its database. whether his patient. The company said it believes the claims in the lawsuit are “unfounded”.

In addition to prescribing, Cerebral also faces close scrutiny for paid social media marketing campaigns and it treat employees.

Meanwhile, mental health tech startups has seen a huge increase in investment last year, and Cerebral was no exception. In December, Cerebral claims to have raised $300 millionabout six months after Series B worth $127 million. The company launched in 2020.

ON PROFILE

“This transformational program reflects a new focus on strengthening Cerebral’s foundation,” Chief Executive Officer, Dr David Mou said in a statement. “We are confident that the initiatives planned will promote more sustainable and stable growth, while on a mission to democratize access to quality mental health care. high for everyone.”



Source link

news5h

News5h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button